PHENELZINE

Course overview

THE FDA-APPROVED INDICATIONS FOR PHENELZINE INCLUDE THE MANAGEMENT OF TREATMENT-RESISTANT DEPRESSION, PANIC DISORDER, AND SOCIAL ANXIETY DISORDER. PHENELZINE IS ALSO SPECIFICALLY USEFUL FOR YOUNG WOMEN WHO HAVE DEPRESSION AND MOOD DISORDERS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR PHENELZINE AS A VALUABLE AGENT IN TREATING AND MANAGING TREATMENT-RESISTANT DEPRESSION. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EFFECTS, AND OTHER KEY FACTORS SUCH AS DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT AND CARE OF PATIENTS WITH DEPRESSION AND RELATED CONDITIONS.